Intuitive History

Intuitive has been advancing minimally invasive care since 1995 with the goal of helping physicians improve the lives of people around the world. As we move forward, we continue to invest in minimally invasive robotic-assisted surgical and bronchoscopy solutions that contribute to care teams’ goals of better patient care, greater efficiencies, and improved access to quality health care.

1995

Year Intuitive is founded

2000

Year Intuitive launches the da Vinci surgical system

5

Number of generations of da Vinci systems

2019

Year Intuitive launches the Ion endoluminal system

First da Vinci surgeon console from 1996

1995-2004

From prototype to first install. The Intuitive story started in 1995 when bright minds with a common vision and the drive to do something completely new helped change the face of surgery. In 2000, we launched the first da Vinci surgical system. In the hands of experienced surgeons, our minimally invasive surgical system found applications—such as urology—rapidly expanding the opportunity for robotic-assisted surgery.

Explore da Vinci’s impact on urology

2005–2013

Going global. Our technology arrived on the global scene with clearances in new countries and a growing presence around the world. In 2006, we launched our second-generation da Vinci S surgical system. From 2009 to 2013, we saw rapid innovation to our instruments and accessories, services, and the launch of da Vinci Si—our third-generation system designed to enhance training and the overall surgeon experience.

Explore our systems

2014–2024

Broadening adoption. The pace intensified with new products, increased customer adoption, and a growing team of global talent dedicated to our mission. The technology kept getting better as surgeons harnessed our fourth-generation systems: the da Vinci X, da Vinci Xi, and our first single-port system—da Vinci SP. Our horizons expanded beyond surgery in 2019 when we launched Ion–a robotic-assisted bronchoscopy system designed to improve the biopsy of suspicious lung nodules, with the goal to help pulmonologists detect lung cancer sooner.

More about Ion

Surgeon manipulating da Vinci 5 surgeon console

2024+

Surgery, transformed. Bringing to the world our most advanced and integrated robotic surgery system ever—da Vinci 5. Built on the legacy of previous da Vinci systems, da Vinci 5 offers improved ergonomics¹, over 10,000x the computing power², and first-of-its-kind Force Feedback technology to enhance surgical senses. Looking to the future our goal remains the same—to deeply understand the customer experience, improve the overall surgical ecosystem, and continue to expand the potential of physicians to heal without constraints.

Discover da Vinci 5

1. Compared to da Vinci X, Xi, and SP systems. Data on file at Intuitive.
2. Compared to da Vinci Xi. Data on file at Intuitive.

Disclosures and important safety information

Important safety information

Serious complications may occur in any surgery, including da Vinci surgery, up to and including death. Serious risks include, but are not limited to, injury to tissues and organs and conversion to other surgical techniques which could result in a longer operative time and/or increased complications. For summary of the risks associated with surgery refer to www.intuitive.com/safety.

For product intended use and/or indications for use, risks, cautions, and warnings and full prescribing information, refer to the associated user manual(s) or visit https://manuals.intuitivesurgical.com/market.

Individual outcomes may depend on a number of factors—including but not limited to—patient characteristics, disease characteristics, and/or surgeon experience.

Da Vinci Xi/X system

The demonstration of safety and effectiveness for the representative specific procedures did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease-free survival, local recurrence), except for radical prostatectomy which was evaluated for overall survival, or treatment of the patient’s underlying disease/condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon.

Da Vinci SP system

The safety and effectiveness of this device for use in the performance of general laparoscopic surgery procedures have not been established. This device is only intended to be used for single port urological and general thoracoscopic surgical procedures and for transoral otolaryngology surgical procedures in the oropharynx for benign tumors and malignant tumors classified as T1 and T2 with the da Vinci EndoWrist SP Instruments and the da Vinci SP Surgical System (SP1098).

Ion endoluminal system

The Ion endoluminal system (Model IF1000) assists the user in navigating a catheter and endoscopic tools in the pulmonary tract using endoscopic visualization of the tracheobronchial tree for diagnostic and therapeutic procedures. The Ion endoluminal system enables fiducial marker placement. It does not make a diagnosis and is not for pediatric use. Information provided by the Ion endoluminal system or its components should be considered guidance only and not replace clinical decisions made by a trained physician.

Da Vinci 5 system

For risks, cautions, and warnings and full prescribing information, refer to the associated da Vinci 5 surgical system user manual(s).

Contraindication

Use of the Force Feedback needle driver is contraindicated in hysterectomy and myomectomy due to the risk of vaginal bleeding requiring hospital readmission and/or the need for additional procedures. The use of non-force feedback needle drivers is recommended for suturing in these procedures.

Precaution for representative uses

The demonstration of safety and effectiveness for the representative-specific procedures was based on evaluation of the device as a surgical tool and did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease-free survival, local recurrence) or treatment of the patient’s underlying disease or condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon.